Population
9,824 participants from the Framingham Heart Study, age 40 to 89 years, 54% women.
Design
Cohort
Follow-up
212,539 person-years
Authors
Loading...
Evolving AMI diagnostics likely mask true incidence declines and fatality improvements; leaves open accurate assessment of modern trends without standardized criteria.
The apparent stability in national AMI rates over 4 decades is likely due to a doubling of biomarker-diagnosed AMIs, which masks a 50% decline in ECG-diagnosed AMIs and a 60% reduction in case fatality.
Parikh et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: